CDRH Sets 2013 Strategic Priorities
This article was originally published in The Gray Sheet
Executive Summary
Topics include anticipated guidance efforts, as well as emphasis on the work of the center’s nascent entrepreneurs-in-residence program.
You may also be interested in...
CDRH Focusing On New PMA Pathway, Clinical Trials Program In 2014/2015 Priorities
CDRH Director Jeffrey Shuren discussed the device center’s two-year strategic priorities with “The Gray Sheet.” The center plans to rebalance pre-market and post-market data collection, when appropriate, and improve the processes for starting up clinical trials in the U.S.
CDRH Focusing On New PMA Pathway, Clinical Trials Program In 2014/2015 Priorities
CDRH Director Jeffrey Shuren discussed the device center’s two-year strategic priorities with “The Gray Sheet.” The center plans to rebalance pre-market and post-market data collection, when appropriate, and improve the processes for starting up clinical trials in the U.S.
FDA Launches Voluntary Compliance Improvement Pilot
The Office of Compliance pilot aims to challenge companies with less-than-stellar quality systems to improve compliance at their facilities without undergoing an inspection.